EatDrama
Lifestyle

Dispatch Bio launches its first clinical trial to develop a universal treatment for solid cancers

Dispatch Bio launches its first clinical trial to develop a universal treatment for solid cancers

The Penn spinout launched a year ago with CAR-T pioneer Carl June as a scientific co-founder and $216 million in funding from private investors. It dosed its first patient in a clinical trial.

Open original source

Article discussion

Comments stay attached to this story.

No comments yet.

Write a drama, celeb, gossip, or lifestyle post

Start a connected post from this article without changing the original story.

Featured Creators

Creators building their communities through the SpiderTaz Creator Program.

View creators →